Results 71 to 80 of about 34,487 (256)

The use of low‐dose dexmedetomidine constant rate infusion to stabilise blood glucose in a domestic ferret (Mustela putorius furo) with insulinoma undergoing sevoflurane anaesthesia

open access: yesVeterinary Record Case Reports, Volume 13, Issue 4, December 2025.
Abstract A 5.5‐year‐old, male domestic ferret (Mustela putorius furo) diagnosed with insulinoma was presented for a dental procedure under general anaesthesia. In insulinoma patients, it is essential to avoid hypoglycaemia. In other species, constant rate infusion of dexmedetomidine has been reported to sustain adequate blood glucose by inhibiting ...
Anika R. Schiele   +3 more
wiley   +1 more source

Unmasked insulinoma occasioned by severe hypoglycemic coma immediately postpartum: a case report

open access: yesBMC Endocrine Disorders, 2023
Background Insulinoma in women during pregnancy and postpartum is very rare; approximately 65% of cases are diagnosed early in pregnancy and ~ 35% immediately after delivery, few being found in middle or late pregnancy, likely due to increased insulin ...
Kiyoshi Matsumoto   +13 more
doaj   +1 more source

Insulinoma detectado por ultrasonografía endoscópica: reporte de un caso [PDF]

open access: yes, 2007
Los insulinomas son tumores de las células de los islotes del páncreas que desarrollan síntomas de hipoglucemia debido a una secreción inapropiada de insulina.
Garza Galindo, Aldo Azael   +2 more
core  

Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1 [PDF]

open access: yes, 2013
Functional pancreatic neuroendocrine tumours (PNETs) are mainly represented by insulinoma, which secrete insulin independent of glucose and cause hypoglycaemia. The major genetic alterations in sporadic insulinomas are still unknown.
Cai, Jie   +19 more
core   +1 more source

Adult-Onset Focal Nesidioblastosis With Nodular Formation Mimicking Insulinoma [PDF]

open access: gold, 2021
Shunsuke Doi   +9 more
openalex   +1 more source

INSULINOMA MALIGNO

open access: yesRevista de la Facultad de Medicina Humana, 2017
El insulinoma es el tumor neuroendocrino del páncreas más frecuente. Se presenta el caso de un paciente de 54 años de edad. La sintomatología conocida por la disminución severa de la glicemia en el sistema nervioso central, el diagnostico se basó en la evidencia de hipoglicemia, asociado a niveles elevados de insulina.
Herrera-Favian, Pedro Roberto   +2 more
openaire   +4 more sources

Insulinoma in a dog (Canis lupus familiaris) with concurrent non‐cardiogenic pulmonary oedema

open access: yesVeterinary Record Case Reports, Volume 13, Issue 4, December 2025.
Abstract A 12‐year‐old, female, neutered beagle presented with hypoglycaemia, sudden‐onset non‐ambulatory tetraparesis and a single tonic‐clonic seizure. Computed tomography revealed a pancreatic nodule, consistent with an insulinoma, an enlarged hepatic lymph node and ground‐glass attenuation of the lung parenchyma, most consistent with non ...
Dylan O’ Toole   +5 more
wiley   +1 more source

A Case Report of Insulinoma Treated for Refractory Seizures

open access: yesJournal of Medical Sciences and Health, 2018
Insulinoma is a functional endocrine tumor of the pancreas that secretes insulin. Insulinoma comprises 25% of the pancreatic endocrine tumors. Patients may have heterogeneous presentation of symptoms varying from mild autonomic symptoms to severe ...
Shreemit Maheshwari   +4 more
doaj  

Endogenous hyperinsulinism: diagnostic and therapeutic difficulties

open access: yesThe Pan African Medical Journal, 2019
Endogenous hyperinsulinism is an abnormal clinical condition that involves excessive insulin secretion, related in 55% of cases to insulinoma. Other causes are possible such as islet cell hyperplasia, nesidioblastosis or antibodies to insulin or to the ...
Esma Leila Gouta   +6 more
doaj   +1 more source

A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide

open access: yesClinical Case Reports, 2021
Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.
Keiko Yamaoka   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy